Correlates of antiviral immune restoration in acute and chronic HIV type 1 infection: Sustained viral suppression and normalization of T cell subsets

被引:15
作者
Dyer, WB [1 ]
Kuipers, H
Coolen, MW
Geczy, AF
Forrester, J
Workman, C
Sullivan, JS
机构
[1] Australian Red Cross Blood Serv, Sydney, NSW 2000, Australia
[2] AIDS Res Initiat, Darlinghurst, NSW 2010, Australia
关键词
D O I
10.1089/08892220260235362
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Highly active antiretroviral therapy (HAART) has suppressed viral replication and facilitated normalization of T cell subsets, resulting in restoration of immunity against opportunistic pathogens. Induction of full immune restoration in chronically infected individuals, including HIV-specific helper T cell responses, is considered a priority, particularly if immunological control of HIV is to be achieved. Regimens containing dual protease inhibitors (PIs) have provided greater suppression of viremia than single-PI regimens. We therefore conducted a prospective analysis of factors associated with immune restoration after 3 years of therapy in two cohorts of acutely and chronically HIV-infected patients, comparing dual-versus single-PI regimens. Earlier and more durable returns of p24-specific proliferation were demonstrated in patients receiving dual-PI compared with single-PI regimens. Individuals with restored p24 responses had larger reductions in total HIV-specific cytotoxic T lymphocytes (CTLs) associated with stronger viral suppression, but Gag-specific CTLs remained higher, demonstrating that Gag-specific helper T cell responses were a critical component of functional immune restoration. On examination of clinical factors associated with immune restoration, we demonstrated that decreasing activation of CD8(+) T cells (% CD8(+)CD38(+)) and increasing proportions of CD4(+) T cells were independently associated with restoration of p24 responses. Minimal immune activation, resulting from maximal suppression of viral replication, was required for long-term restoration and maintenance of Gag-specific T cell responses. This study uniquely demonstrates that dual-PI regimens are superior in achieving these levels of virological control and immune restoration in both chronic and acute infection, compared with single-PI or non-PI regimens.
引用
收藏
页码:999 / 1010
页数:12
相关论文
共 49 条
[1]   Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease [J].
Al-Harthi, L ;
Siegel, J ;
Spritzler, J ;
Pottage, J ;
Agnoli, M ;
Landay, A .
AIDS, 2000, 14 (07) :761-770
[2]   Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection [J].
Altfeld, M ;
Rosenberg, ES ;
Shankarappa, R ;
Mukherjee, JS ;
Hecht, FM ;
Eldridge, RL ;
Addo, MM ;
Poon, SH ;
Phillips, MN ;
Robbins, GK ;
Sax, PE ;
Boswell, S ;
Kahn, JO ;
Brander, C ;
Goulder, PJR ;
Levy, JA ;
Mullins, JI ;
Walker, BD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :169-180
[3]   Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir [J].
Angel, JB ;
Kumar, A ;
Parato, K ;
Filion, LG ;
Diaz-Mitoma, F ;
Daftarian, P ;
Pham, B ;
Sun, E ;
Leonard, JM ;
Cameron, DW .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04) :898-904
[4]   Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression [J].
Angel, JB ;
Parato, KG ;
Kumar, A ;
Kravcik, S ;
Badley, AD ;
Fex, C ;
Ashby, D ;
Sun, E ;
Cameron, DW .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04) :546-554
[5]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[6]   The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy [J].
Binley, JM ;
Schiller, DS ;
Ortiz, GM ;
Hurley, A ;
Nixon, DF ;
Markowitz, MM ;
Moore, JP .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (04) :1249-1263
[7]   Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution [J].
Blankson, JN ;
Gallant, JE ;
Siliciano, RF .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04) :657-661
[8]   Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy [J].
Condra, JH ;
Petropoulos, CJ ;
Ziermann, R ;
Schleif, WA ;
Shivaprakash, M ;
Emini, EA .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (03) :758-765
[9]   Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response [J].
Connick, E ;
Lederman, MM ;
Kotzin, BL ;
Spritzler, J ;
Kuritzkes, DR ;
St Clair, M ;
Sevin, AD ;
Fox, L ;
Chiozzi, MH ;
Leonard, JM ;
Rousseau, F ;
Roe, JD ;
Martinez, A ;
Kessler, H ;
Landay, A .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :358-363
[10]   Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney blood bank cohort patients infected with nef-defective HIV type 1 [J].
Dyer, WB ;
Ogg, GS ;
Demoitie, MA ;
Jin, X ;
Geczy, AF ;
Rowland-Jones, SL ;
McMichael, AJ ;
Nixon, DF ;
Sullivan, JS .
JOURNAL OF VIROLOGY, 1999, 73 (01) :436-443